177 related articles for article (PubMed ID: 34619334)
21. Genomic perspective of triazole resistance in clinical and environmental Aspergillus fumigatus isolates without cyp51A mutations.
Sharma C; Nelson-Sathi S; Singh A; Radhakrishna Pillai M; Chowdhary A
Fungal Genet Biol; 2019 Nov; 132():103265. PubMed ID: 31465846
[TBL] [Abstract][Full Text] [Related]
22. Prospective evaluation of azole resistance in Aspergillus fumigatus clinical isolates in France.
Choukri F; Botterel F; Sitterlé E; Bassinet L; Foulet F; Guillot J; Costa JM; Fauchet N; Dannaoui E
Med Mycol; 2015 Aug; 53(6):593-6. PubMed ID: 26026171
[TBL] [Abstract][Full Text] [Related]
23. Isolation of multiple-triazole-resistant Aspergillus fumigatus strains carrying the TR/L98H mutations in the cyp51A gene in India.
Chowdhary A; Kathuria S; Randhawa HS; Gaur SN; Klaassen CH; Meis JF
J Antimicrob Chemother; 2012 Feb; 67(2):362-6. PubMed ID: 22028200
[TBL] [Abstract][Full Text] [Related]
24. Surveillance for azole resistance in clinical and environmental isolates of Aspergillus fumigatus in Australia and cyp51A homology modelling of azole-resistant isolates.
Talbot JJ; Subedi S; Halliday CL; Hibbs DE; Lai F; Lopez-Ruiz FJ; Harper L; Park RF; Cuddy WS; Biswas C; Cooley L; Carter D; Sorrell TC; Barrs VR; Chen SC
J Antimicrob Chemother; 2018 Sep; 73(9):2347-2351. PubMed ID: 29846581
[TBL] [Abstract][Full Text] [Related]
25. Low prevalence of resistance to azoles in Aspergillus fumigatus in a French cohort of patients treated for haematological malignancies.
Alanio A; Sitterlé E; Liance M; Farrugia C; Foulet F; Botterel F; Hicheri Y; Cordonnier C; Costa JM; Bretagne S
J Antimicrob Chemother; 2011 Feb; 66(2):371-4. PubMed ID: 21131690
[TBL] [Abstract][Full Text] [Related]
26. Evaluation of the in vitro activity of isavuconazole and comparator voriconazole against 2635 contemporary clinical Candida and Aspergillus isolates.
Astvad KMT; Hare RK; Arendrup MC
Clin Microbiol Infect; 2017 Nov; 23(11):882-887. PubMed ID: 28373148
[TBL] [Abstract][Full Text] [Related]
27. Clonal expansion and emergence of environmental multiple-triazole-resistant Aspergillus fumigatus strains carrying the TR₃₄/L98H mutations in the cyp51A gene in India.
Chowdhary A; Kathuria S; Xu J; Sharma C; Sundar G; Singh PK; Gaur SN; Hagen F; Klaassen CH; Meis JF
PLoS One; 2012; 7(12):e52871. PubMed ID: 23285210
[TBL] [Abstract][Full Text] [Related]
28. Epidemiological cutoffs and cross-resistance to azole drugs in Aspergillus fumigatus.
Rodriguez-Tudela JL; Alcazar-Fuoli L; Mellado E; Alastruey-Izquierdo A; Monzon A; Cuenca-Estrella M
Antimicrob Agents Chemother; 2008 Jul; 52(7):2468-72. PubMed ID: 18474574
[TBL] [Abstract][Full Text] [Related]
29. Azole antifungal resistance in Aspergillus fumigatus: 2008 and 2009.
Bueid A; Howard SJ; Moore CB; Richardson MD; Harrison E; Bowyer P; Denning DW
J Antimicrob Chemother; 2010 Oct; 65(10):2116-8. PubMed ID: 20729241
[TBL] [Abstract][Full Text] [Related]
30. Relation of the polymorphism of cyp51A sequence and the susceptibility of Aspergillus fumigatus isolates to triazoles determined by commercial gradient test (Etest) and by reference methods.
Nawrot U; Sulik-Tyszka B; Kurzyk E; Mroczyńska M; Włodarczyk K; Wróblewska M; Basak GW; Brillowska-Dąbrowska A
Acta Biochim Pol; 2017; 64(4):631-634. PubMed ID: 29202140
[TBL] [Abstract][Full Text] [Related]
31. High prevalence of clinical and environmental triazole-resistant Aspergillus fumigatus in Iran: is it a challenging issue?
Nabili M; Shokohi T; Moazeni M; Khodavaisy S; Aliyali M; Badiee P; Zarrinfar H; Hagen F; Badali H
J Med Microbiol; 2016 Jun; 65(6):468-475. PubMed ID: 27008655
[TBL] [Abstract][Full Text] [Related]
32. Aspergillus fumigatus harbouring the sole Y121F mutation shows decreased susceptibility to voriconazole but maintained susceptibility to itraconazole and posaconazole.
Lescar J; Meyer I; Akshita K; Srinivasaraghavan K; Verma C; Palous M; Mazier D; Datry A; Fekkar A
J Antimicrob Chemother; 2014 Dec; 69(12):3244-7. PubMed ID: 25125676
[TBL] [Abstract][Full Text] [Related]
33. Aspergillus species collected from environmental air samples in Portugal-molecular identification, antifungal susceptibility and sequencing of cyp51A gene on A. fumigatus sensu stricto itraconazole resistant.
Monteiro C; Pinheiro D; Maia M; Faria MA; Lameiras C; Pinto E
J Appl Microbiol; 2019 Apr; 126(4):1140-1148. PubMed ID: 30735287
[TBL] [Abstract][Full Text] [Related]
34. Examination of cyp51A and cyp51B expression level of the first Polish azole resistant clinical Aspergillus fumigatus isolate.
Brillowska-Dąbrowska A; Mroczyńska M; Nawrot U; Włodarczyk K; Kurzyk E
Acta Biochim Pol; 2015; 62(4):837-9. PubMed ID: 26636140
[TBL] [Abstract][Full Text] [Related]
35. Trends in the activity of mold-active azole agents against
Pfaller MA; Carvalhaes CG; Rhomberg PR; Desphande LM; Castanheira M
J Clin Microbiol; 2024 Feb; 62(2):e0114123. PubMed ID: 38193696
[TBL] [Abstract][Full Text] [Related]
36. Comparative evaluation of different gradient diffusion tests for detection of azole resistance in Aspergillus fumigatus.
Idelevich EA; Groß U; Becker K; Bader O
Diagn Microbiol Infect Dis; 2018 May; 91(1):52-54. PubMed ID: 29422272
[TBL] [Abstract][Full Text] [Related]
37. Multi-triazole-resistant Aspergillus fumigatus infections in Australia.
Kidd SE; Goeman E; Meis JF; Slavin MA; Verweij PE
Mycoses; 2015 Jun; 58(6):350-5. PubMed ID: 25885568
[TBL] [Abstract][Full Text] [Related]
38. Azole Resistance in Aspergillus fumigatus Clinical Isolates from an Italian Culture Collection.
Lazzarini C; Esposto MC; Prigitano A; Cogliati M; De Lorenzis G; Tortorano AM
Antimicrob Agents Chemother; 2016 Jan; 60(1):682-5. PubMed ID: 26552980
[TBL] [Abstract][Full Text] [Related]
39. Activity of Isavuconazole and Other Azoles against Candida Clinical Isolates and Yeast Model Systems with Known Azole Resistance Mechanisms.
Sanglard D; Coste AT
Antimicrob Agents Chemother; 2016 Jan; 60(1):229-38. PubMed ID: 26482310
[TBL] [Abstract][Full Text] [Related]
40. Pesticide behavior in paddy fields and development of azole-resistant Aspergillus fumigatus: Should we be concerned?
Vaezi A; Fakhim H; Javidnia J; Khodavaisy S; Abtahian Z; Vojoodi M; Nourbakhsh F; Badali H
J Mycol Med; 2018 Mar; 28(1):59-64. PubMed ID: 29496370
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
